The MyAirCoach project is organizing the Workshop on Mobile Healthcare for the Self-Management of Chronic Diseases and the Empowerment of Patients in Conjunction with MobileHCI 2016, Florence, Italy.
The world asthma congress has taken place this year in Madrid Spain. The continuous presence and increasing impact of the World Asthma Congress, underlines the importance of effective asthma management and reveals the importance of MyAirCoach objectives and innovation potential.
The Asthma Health project has been released alongside Apple's ResearchKit and aims at the creation of an innovative mobile phone application designed to facilitate asthma patient education and self-monitoring. In a recent development the Asthma Health project has been announced to expand in the United Kingdom and Ireland, taking an important step towards the promotion of mHealth technologies worldwide.
A new type of inhaler may be soon available, promising a significantly smaller and more convenient size.
The Bloom inhaler is about the size of a credit card and can be filled using any Hydrofluoroalkane inhaler and be kept in the patients wallet.
The Bloom inhaler is currently being tested for FDA approval and can be preordered online for a cost of $40
Google doodle today pays tribute to René Laennec. René-Théophile-Hyacinthe Laennec was a French physician. He invented the stethoscope in 1816, while working at the Hôpital Necker and pioneered its use in diagnosing various chest conditions. Link
Read more about the life and work of René Laennec. Link
Standardization is a crucial component of the MyAirCoah solution as it promises the fast and efficient integration of our solution with the global healthcare environment. In a recent article IEEE has focused on the standardization of eHealth technologies and identified that there has been a surge in IEEE standards activities in the health-care field. A new e-health standard was issued to protect biometric data exchanged via smartphones and similar devices.
MyAirCoach consortium member EFA has participated this December in the 27th conference on Drug Delivery on the Lungs in Edinburgh, Scotland. The conference gave a great oportunity for the dissemination of the MyAirCoach objectives and methodology and helped towards the understanding of the commercial and research environment of inhaled drug delivery.
The report from ‘Global Alliance against Respiratory Diseases’ of the World Health Organization is now published including important results regarding actions and progress around the world in care and prevention of respiratory diseases.
Novartis has announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler, for people who have COPD.
Specifically, Qualcomm Life will develop the reference design for the module that will connect the Breezhaler to the Qualcomm Life 2net platform, a hub for connecting home health devices. This platform will collect data on inhaler usage, including the duration of the patient's inhalation, which Novartis said indicates quality of the inhalation.
Last week the MyAirCoach project was presented in the eHealth Forum 2015 in Athens - Greece.